▶ 調査レポート

世界のアルブミン市場2021年ー2031年:製品種類別(ヒト血清アルブミン、組換えアルブミン)、用途別、エンドユーザー別

• 英文タイトル:Albumin Market (Product Type: Human Serum Albumin and Recombinant Albumin; Application: Human Serum Albumin Application [Drug Formulation, Drug Delivery, Vaccines, Medical Device Coating, Culture Medium & Stabilizer, Diagnostics, and In Vitro Fertilization] and Recombinant Albumin Applications [Drug Formulation, Drug Delivery, Vaccines, Medical Device Coating, Culture Medium & Stabilizer, Diagnostics, and In Vitro Fertilization]; and End-user: Pharmaceutical & Biotechnology Companies, Research Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Transparency Market Researchが調査・発行した産業分析レポートです。世界のアルブミン市場2021年ー2031年:製品種類別(ヒト血清アルブミン、組換えアルブミン)、用途別、エンドユーザー別 / Albumin Market (Product Type: Human Serum Albumin and Recombinant Albumin; Application: Human Serum Albumin Application [Drug Formulation, Drug Delivery, Vaccines, Medical Device Coating, Culture Medium & Stabilizer, Diagnostics, and In Vitro Fertilization] and Recombinant Albumin Applications [Drug Formulation, Drug Delivery, Vaccines, Medical Device Coating, Culture Medium & Stabilizer, Diagnostics, and In Vitro Fertilization]; and End-user: Pharmaceutical & Biotechnology Companies, Research Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 / MRC2204B016資料のイメージです。• レポートコード:MRC2204B016
• 出版社/出版日:Transparency Market Research / 2022年4月20日
• レポート形態:英文、PDF、178ページ
• 納品方法:Eメール
• 産業分類:食品
• 販売価格(消費税別)
  Single User¥735,965 (USD5,795)▷ お問い合わせ
  Multi User¥1,116,965 (USD8,795)▷ お問い合わせ
  Corporate License¥1,497,965 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本市場調査資料では、世界のアルブミン市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別(ヒト血清アルブミン、組換えアルブミン)分析、用途別分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況など、以下の構成でまとめました。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界のアルブミン市場規模:製品別(ヒト血清アルブミン、組換えアルブミン)
・世界のアルブミン市場規模:用途別
・世界のアルブミン市場規模:エンドユーザー別
・世界のアルブミン市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

TMR’s report on the global albumin market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global albumin market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global albumin market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global albumin market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global albumin market.

The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global albumin market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global albumin market.

The report delves into the competitive landscape of the global albumin market. Key players operating in the global albumin market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global albumin market that have been profiled in this report.

Key Questions Answered in Global Albumin Market Report
What is the scope of growth of product companies in the global albumin market?
What will be the Y-o-Y growth of the global albumin market between 2017 and 2031?
What is the influence of changing trends in technologies on the global albumin market?
Will Asia Pacific be the most profitable market for albumin providers?
Which factors are anticipated to hamper the growth of the global albumin market during the forecast period?
Which are the leading companies in the global albumin market?
Research Methodology
TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global albumin market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global albumin market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the albumin market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the albumin market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global albumin market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global albumin market more reliably and accurately.

Albumin Market – Segmentation

*** Product Type
Human Serum Albumin
Recombinant Albumin

*** Application
Human Serum Albumin Applications
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Culture Medium & Stabilizer
Diagnostics
In Vitro Fertilization
Recombinant Albumin Applications
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Culture Medium & Stabilizer
Diagnostics
In Vitro Fertilization

*** End-user
Pharmaceutical & Biotechnology Companies
Research Institutes
Others

*** Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Albumin Market

4. Market Overview

4.1. Introduction

4.1.1. Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Albumin Market Analysis and Forecast, 2017–2031

5. Key Insights

5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)

5.2. Regulatory Scenario by Key Countries

5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Albumin Market Analysis and Forecast, by Product

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Product, 2017–2031

6.3.1. Human Serum Albumin

6.3.2. Recombinant Albumin

6.4. Market Attractiveness Analysis, by Product

7. Global Albumin Market Analysis and Forecasts, by Application

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Application, 2017–2031

7.3.1. Human Serum Albumin Applications

7.3.1.1. Drug Formulation

7.3.1.2. Drug Delivery

7.3.1.3. Vaccines

7.3.1.4. Medical Device Coating

7.3.1.5. Culture Media & Stabilizers

7.3.1.6. Diagnostics

7.3.1.7. In Vitro Fertilization

7.3.2. Recombinant Albumin Applications

7.3.2.1. Drug Formulation

7.3.2.2. Drug Delivery

7.3.2.3. Vaccines

7.3.2.4. Medical Device Coating

7.3.2.5. Culture Media & Stabilizers

7.3.2.6. Diagnostics

7.3.2.7. In Vitro Fertilization

8. Global Albumin Market Analysis and Forecast, by End-user

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by End-user, 2017–2031

8.3.1. Pharmaceutical & Biotechnology Companies

8.3.2. Research Institutes

8.3.3. Others

8.4. Market Attractiveness Analysis, by End-user

9. Global Albumin Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Market Attractiveness Analysis, by Region

10. North America Albumin Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Market Value Forecast, by Product, 2017–2031

10.2.1. Human Serum Albumin

10.2.2. Recombinant Albumin

10.3. Market Value Forecast, by Application, 2017–2031

10.3.1. Human Serum Albumin Applications

10.3.1.1. Drug Formulation

10.3.1.2. Drug Delivery

10.3.1.3. Vaccines

10.3.1.4. Medical Device Coating

10.3.1.5. Culture Media & Stabilizers

10.3.1.6. Diagnostics

10.3.1.7. In Vitro Fertilization

10.3.2. Recombinant Albumin Applications

10.3.2.1. Drug Formulation

10.3.2.2. Drug Delivery

10.3.2.3. Vaccines

10.3.2.4. Medical Device Coating

10.3.2.5. Culture Media & Stabilizers

10.3.2.6. Diagnostics

10.3.2.7. In Vitro Fertilization

10.4. Market Value Forecast, by End-user, 2017–2031

10.4.1. Pharmaceutical & Biotechnology Companies

10.4.2. Research Institutes

10.4.3. Others

10.5. Market Value Forecast, by Country, 2017–2031

10.5.1. U.S.

10.5.2. Canada

10.6. Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By Application

10.6.3. By End-user

10.6.4. By Country

11. Europe Albumin Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Market Value Forecast, by Product, 2017–2031

11.2.1. Human Serum Albumin

11.2.2. Recombinant Albumin

11.3. Market Value Forecast, by Application, 2017–2031

11.3.1. Human Serum Albumin Applications

11.3.1.1. Drug Formulation

11.3.1.2. Drug Delivery

11.3.1.3. Vaccines

11.3.1.4. Medical Device Coating

11.3.1.5. Culture Media & Stabilizers

11.3.1.6. Diagnostics

11.3.1.7. In Vitro Fertilization

11.3.2. Recombinant Albumin Applications

11.3.2.1. Drug Formulation

11.3.2.2. Drug Delivery

11.3.2.3. Vaccines

11.3.2.4. Medical Device Coating

11.3.2.5. Culture Media & Stabilizers

11.3.2.6. Diagnostics

11.3.2.7. In Vitro Fertilization

11.4. Market Value Forecast, by End-user, 2017–2031

11.4.1. Pharmaceutical & Biotechnology Companies

11.4.2. Research Institutes

11.4.3. Others

11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Italy

11.5.5. Spain

11.5.6. Rest of Europe

11.6. Market Attractiveness Analysis

11.6.1. By Product

11.6.2. By End-user

11.6.3. By Country/Sub-region

12. Asia Pacific Albumin Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast, by Product, 2017–2031

12.2.1. Human Serum Albumin

12.2.2. Recombinant Albumin

12.3. Market Value Forecast by Application, 2017–2031

12.3.1. Human Serum Albumin Applications

12.3.1.1. Drug Formulation

12.3.1.2. Drug Delivery

12.3.1.3. Vaccines

12.3.1.4. Medical Device Coating

12.3.1.5. Culture Media & Stabilizers

12.3.1.6. Diagnostics

12.3.1.7. In Vitro Fertilization

12.3.2. Recombinant Albumin Applications

12.3.2.1. Drug Formulation

12.3.2.2. Drug Delivery

12.3.2.3. Vaccines

12.3.2.4. Medical Device Coating

12.3.2.5. Culture Media & Stabilizers

12.3.2.6. Diagnostics

12.3.2.7. In Vitro Fertilization

12.4. Market Value Forecast, by Product, 2017–2031

12.4.1. Pharmaceutical & Biotechnology Companies

12.4.2. Research Institutes

12.4.3. Others

12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

12.5.1. China

12.5.2. Japan

12.5.3. South Korea

12.5.4. India

12.5.5. Australia & New Zealand

12.5.6. Rest of Asia Pacific

12.6. Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By Application

12.6.3. By End-user

12.6.4. By Country/Sub-region

13. Latin America Albumin Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast, by Product, 2017–2031

13.2.1. Human Serum Albumin

13.2.2. Recombinant Albumin

13.3. Market Value Forecast by Application, 2017–2031

13.3.1. Human Serum Albumin Applications

13.3.1.1. Drug Formulation

13.3.1.2. Drug Delivery

13.3.1.3. Vaccines

13.3.1.4. Medical Device Coating

13.3.1.5. Culture Media & Stabilizers

13.3.1.6. Diagnostics

13.3.1.7. In Vitro Fertilization

13.3.2. Recombinant Albumin Applications

13.3.2.1. Drug Formulation

13.3.3. Drug Delivery

13.3.3.1. Vaccines

13.3.3.2. Medical Device Coating

13.3.3.3. Culture Media & Stabilizers

13.3.3.4. Diagnostics

13.3.3.5. In Vitro Fertilization

13.4. Market Value Forecast, by End-user, 2017–2031

13.4.1. Pharmaceutical & Biotechnology Companies

13.4.2. Research Institutes

13.4.3. Others

13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Market Attractiveness Analysis

13.6.1. By Product

13.6.2. By Application

13.6.3. By End-user

13.6.4. By Country/Sub-region

14. Middle East & Africa Albumin Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Market Value Forecast, by Product, 2017–2031

14.2.1. Human Serum Albumin

14.2.2. Recombinant Albumin

14.3. Market Value Forecast, by End-user, 2017–2031

14.3.1. Pharmaceutical & Biotechnology Companies

14.3.2. Research Institutes

14.3.3. Others

14.4. Market Value Forecast, by Country/Sub-region, 2017–2031

14.4.1. GCC Countries

14.4.2. South Africa

14.4.3. Rest of Middle East & Africa

14.5. Market Attractiveness Analysis

14.5.1. By Product

14.5.2. By Application

14.5.3. By End-user

14.5.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player – Competition Matrix (by tier and size of companies)

15.2. Market Share Analysis, by Company, 2020

15.3. Company Profiles

15.3.1. Albumedix A/S

15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.1.2. Financial Analysis

15.3.1.3. Growth Strategies

15.3.1.4. SWOT Analysis

15.3.2. Albumin Therapeutics, LLC

15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.2.2. Financial Analysis

15.3.2.3. Growth Strategies

15.3.2.4. SWOT Analysis

15.3.3. Biotest AG

15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.3.2. Financial Analysis

15.3.3.3. Growth Strategies

15.3.3.4. SWOT Analysis

15.3.4. CSL Behring LLC

15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.4.2. Financial Analysis

15.3.4.3. Growth Strategies

15.3.4.4. SWOT Analysis

15.3.5. Grifols International, S.A.

15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.5.2. Financial Analysis

15.3.5.3. Growth Strategies

15.3.5.4. SWOT Analysis

15.3.6. HiMedia Laboratories Pvt. Ltd.

15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.6.2. Financial Analysis

15.3.6.3. Growth Strategies

15.3.6.4. SWOT Analysis

15.3.7. InVitria

15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.7.2. Financial Analysis

15.3.7.3. Growth Strategies

15.3.7.4. SWOT Analysis

15.3.8. Medxbio Pte Ltd.

15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.8.2. Financial Analysis

15.3.8.3. Growth Strategies

15.3.8.4. SWOT Analysis

15.3.9. Octapharma AG

15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.9.2. Financial Analysis

15.3.9.3. Growth Strategies

15.3.9.4. SWOT Analysis

15.3.10. RayBiotech, Inc.

15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.10.2. Financial Analysis

15.3.10.3. Growth Strategies

15.3.10.4. SWOT Analysis

15.3.11. Seracare Life Sciences (LGC)

15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.11.2. Financial Analysis

15.3.11.3. Growth Strategies

15.3.11.4. SWOT Analysis

15.3.11.5. SWOT Analysis

15.3.12. Sigma-Aldrich Co. (Merck KGaA)

15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.12.2. Financial Analysis

15.3.12.3. Growth Strategies

15.3.12.4. SWOT Analysis

15.3.13. Takeda Pharmaceutical Company Limited (Shire)

15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.13.2. Financial Analysis

15.3.13.3. Growth Strategies

15.3.13.4. SWOT Analysis

List of Tables

Table 01: Global Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031

Table 04: Global Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031

Table 05: Global Albumin Market Value (US$ Mn), Forecast, 2017–2031

Table 06: Global Albumin Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Albumin Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 08: North America Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 09: North America Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 10: North America Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031

Table 11: North America Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031

Table 12: North America Albumin Market Value (US$ Mn), Forecast, by End-user, 2017–2031

Table 13: Europe Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 14: Europe Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 15: Europe Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Europe Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031

Table 17: Europe Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031

Table 18: Europe Albumin Market Value (US$ Mn), Forecast, by End-user, 2017–2031

Table 19: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 20: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 21: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 22: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031

Table 23: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031

Table 24: Asia Pacific Albumin Market Value (US$ Mn), Forecast, 2017–2031

Table 25: Latin America Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 26: Latin America Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 27: Latin America Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 28: Latin America Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031

Table 29: Latin America Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031

Table 30: Latin America Albumin Market Value (US$ Mn), Forecast, 2017–2031

Table 31: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 32: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 33: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 34: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031

Table 35: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031

Table 36: Middle East & Africa Albumin Market Value (US$ Mn), Forecast, 2017–2031

List of Figures

Figure 01: Global Albumin market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Albumin market Value Share, by Product Type, 2020

Figure 03: Global Albumin market Value Share, by End-user, 2020

Figure 04: Global Albumin market Value Share, by Region, 2020

Figure 05: Global Albumin Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 06: Global Albumin Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 07: Global Albumin Market Revenue (US$ Mn), by Human Serum Albumin, 2017–2031

Figure 08: Global Albumin Market Revenue (US$ Mn), by Recombinant Albumin, 2017–2031

Figure 09: Global Albumin Market Value Share Analysis, by Application, 2020 and 2031

Figure 10: Global Albumin Market Attractiveness Analysis, by Application, 2021–2031

Figure 11: Global Albumin Market Revenue (US$ Mn), by Human Serum Albumin Applications, 2017–2031

Figure 12: Global Albumin Market Revenue (US$ Mn), by Recombinant Albumin Applications, 2017–2031

Figure 13: Global Albumin Market, by End-user, 2020 and 2031

Figure 14: Global Albumin Market, by End-user, 2021–2031

Figure 15: Global Albumin Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031

Figure 16: Global Albumin Market (US$ Mn), by Research Institutes, 2017–2031

Figure 17: Global Albumin Market (US$ Mn), by Others, 2017–2031

Figure 18: Global Albumin Market Value Share Analysis, by Region, 2020 and 2031

Figure 19: Global Albumin Market Attractiveness Analysis, by Region, 2021–2031

Figure 20: North America Albumin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 21: North America Albumin Market Value Share Analysis, by Country, 2020 and 2031

Figure 22: North America Albumin Market Attractiveness Analysis, by Country, 2021–2031

Figure 23: North America Albumin Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 24: North America Albumin Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 25: North America Albumin Market Value Share Analysis, by Application, 2020 and 2031

Figure 26: North America Albumin Market Attractiveness Analysis, by Application, 2021–2031

Figure 27: North America Albumin Market, by End-user, 2020 and 2031

Figure 28: North America Albumin Market, by End-user, 2021–2031

Figure 29: Europe Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 30: Europe Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 31: Europe Albumin Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 32: Europe Albumin Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 33: Europe Albumin Market Value Share Analysis, by Application, 2020 and 2031

Figure 34: Europe Albumin Market Attractiveness Analysis, by Application, 2021–2031

Figure 35: Europe Albumin Market, by End-user, 2020 and 2031

Figure 36: Europe Albumin Market, by End-user, 2021–2031

Figure 37: Asia Pacific Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 38: Asia Pacific Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 39: Asia Pacific Albumin Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 40: Asia Pacific Albumin Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 41: Asia Pacific Albumin Market Value Share Analysis, by Application, 2020 and 2031

Figure 42: Asia Pacific Albumin Market Attractiveness Analysis, by Application, 2021–2031

Figure 43: Asia Pacific Albumin Market, by End-user, 2020 and 2031

Figure 44: Asia Pacific Albumin Market, by End-user, 2021–2031

Figure 45: Latin America Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 46: Latin America Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 47: Latin America Albumin Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 48: Latin America Albumin Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 49: Latin America Albumin Market Value Share Analysis, by Application, 2020 and 2031

Figure 50: Latin America Albumin Market Attractiveness Analysis, by Application, 2021–2031

Figure 51: Latin America Albumin Market, by End-user, 2020 and 2031

Figure 52: Latin America Albumin Market, by End-user, 2021–2031

Figure 53: Middle East & Africa Albumin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 54: Middle East & Africa Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 55: Middle East & Africa Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 56: Middle East & Africa Albumin Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 57: Middle East & Africa Albumin Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 58: Middle East & Africa Albumin Market Value Share Analysis, by Application, 2020 and 2031

Figure 59: Middle East & Africa Albumin Market Attractiveness Analysis, by Application, 2021–2031

Figure 60: Middle East & Africa Albumin Market, by End-user, 2020 and 2031

Figure 61: Middle East & Africa Albumin Market, by End-user, 2021–2031

Figure 62: Global Albumin Market Share, by Company, 2021